Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

Author(s): El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI

Department of Pharmacology and Toxicology, Medical College of Georgia, 1120 15th St., Augusta, GA 30912, USA

Subject: Diabetes View the study


Diabetic retinopathy is characterized by blood-retinal barrier (BRB) breakdown and neurotoxicity. These pathologies have been associated with oxidative stress and proinflammatory cytokines, which may operate by activating their downstream target p38 MAP kinase. In the present study, the protective effects of a nonpsychotropic cannabinoid, cannabidiol (CBD), were examined in streptozotocin-induced diabetic rats after 1, 2, or 4 weeks.

Source: The American Journal of Pathology
Share Tweet

More medical studies related to Diabetes:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

на сайте